Immunocore Holdings plc 8-K

What Happened Immunocore Holdings plc announced its financial results for the quarter ended March 31, 2026 and other corporate updates in a press release issued May 6, 2026. The company furnished that press release as Exhibit 99.1 to its Form 8-K (Item 2.02), which was filed with the SEC on May 6, 2026.

Key Details

• Filing date: May 6, 2026; quarter covered: quarter ended March 31, 2026.
• Event: Press release announcing first-quarter 2026 financial results and additional corporate updates.
• The press release is furnished as Exhibit 99.1 to the Form 8-K and incorporated by reference; the filing also includes the Inline XBRL cover page (Exhibit 104).
• Reported under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits).

Why It Matters This 8-K signals that Immunocore has publicly released its quarterly earnings and related corporate updates—information investors use to assess recent revenue, earnings, cash position, and business progress. Retail investors should review the furnished press release (Exhibit 99.1) for the detailed quarterly figures, management commentary and any updates on product development or guidance, then follow the company’s full earnings materials and subsequent SEC filings for complete financial statements and disclosures.